Terazosin Hydrochloride Anhydrous - Terazosin Hydrochloride Anhydrous
Navigation: NDC > Supplier starting with: U > UDL LABORATORIES, INC.| Field | Value |
|---|---|
| NDC Code: | 51079-937 |
| Proprietary Name: | Terazosin Hydrochloride Anhydrous |
| Suffix: | |
| Non-Proprietary Name: | Terazosin Hydrochloride Anhydrous |
| Dosage Form: | CAPSULE |
| Method: | ORAL |
| Original Marketing Date: | 28-01-2011 |
| Category Name: | ANDA |
| Application Number: | ANDA075140 |
| Labeler: | UDL LABORATORIES, INC. |
| Substance Name: | TERAZOSIN HYDROCHLORIDE ANHYDROUS |
| Active Numerator Strength: | 2 |
| Active Ingredient Unit: | mg/1 |
| Pharm Classes: | Adrenergic alpha-Antagonists [MoA],alpha-Adrenergic Blocker [EPC] |
| DEA Schedule: |